Center for Biomedical Innovation

Center for Biomedical Innovation

<p>CBI’s mission is to improve global health by overcoming obstacles to the development and implementation of biomedical innovation. CBI provides a safe and transparent environment for collaborative research among industry, academia, and government, and draws on the expertise of the MIT’s Schools of Engineering, Science, and Management, as well as the Harvard-MIT Division of Health Sciences and Technology (HST). In this unique setting, CBI addresses profound challenges in the global biomedical industry by developing, testing, and disseminating new knowledge and tools designed for real world application. CBI’s current activities include the BIOMAN biomanufacturing program, the Consortium on Adventitious Agents in Biomanufacturing, New Drug Development Paradigms (NEWDIGS), and the Sanofi Biomedical Innovation Award Program.</p>